AHK-Cu: research reference

A combination needs its own evidence for a claim about that combination. Component references must remain identified as component evidence.

Copper coordination by the histidine-lysine motif is analogous to that described for other copper tripeptides. Its effect is studied in relation to proliferation pathways in cellular models.

The purity value is a product-label specification, not an assay result. A batch result can only be asserted from that batch’s certificate.

These names help identify the catalog entry. A descriptive label is not evidence of efficacy, and structural identity still requires appropriate documentation.

Copper complex

Reconstitution: Laboratory procedure: allow the closed vial to reach room temperature, disinfect the septum and slowly transfer the diluent against the inner wall of the vial. Do not shake; gently swirl the vial until fully dissolved. Record the volume, diluent and date in the batch log.

Storage: Sealed vial of lyophilized material: store at −20 °C, protected from light and moisture. Avoid repeated freeze-thaw cycles of reconstituted material; aliquot when the experimental design permits.

Personal protective equipment: Handle in a clean work area with a lab coat, nitrile gloves and eye protection. Dispose of vials, tips and sharps according to the laboratory waste procedure.

The short indexed bibliography naming this complex rests on a 2007 dermatological experiment with living human hair follicles ex vivo and dermal-papilla cultures, specialized bulb fibroblasts (17703734). Measurements included follicle elongation and papilla-cell counts. Annexin V/propidium iodide flow cytometry counted apoptotic cells, while immunodetection measured Bcl-2/Bax and cleaved caspase-3 and PARP. Tested concentrations were in the picomolar and nanomolar ranges.

The 2018 Differentiation paper does not examine this copper complex. It tested AHK linked to a vitamin C derivative without copper in mouse C2C12 myoblasts, measuring proliferation, ERK1/2 and Smad1/5/8 phosphorylation, BMP-2-stimulated alkaline phosphatase and Runx2 and osteocalcin transcripts (29567599). It is a bone model with a related molecule, not the same skin material. A 2026 short-peptide hair-loss review organizes families, places this complex among proangiogenic peptides and notes limited characterization compared with the glycine analog (42072405). Sources: PMID 17703734; PMID 29567599; PMID 42072405.

No indexed study publishes a half-life, clearance or blood-concentration curve for this complex. The following findings concern its chemical family rather than a separately measured AHK-Cu profile.

The copper-binding amino-terminal-motif review groups Xxx-His sequences and describes high-affinity copper complexes with limited redox chemistry in their oxidized state (29336493). Albumin has its own amino-terminal copper site, so plasma complexes of this class compete with an abundant protein for the ion. Ternary complexes between albumin and the glycine copper tripeptide, held through albumin-histidine imidazole nitrogens, were subsequently characterized in vitro (34730942); no equivalent measurement is published for the alanine sequence. The short-peptide review links nanosystem formulation work to limited chain stability and permeation (42072405). Sources: PMID 29336493; PMID 34730942; PMID 42072405.

The molecule comes from coordination chemistry rather than a clinical program. Related human-origin examples are the glycine-starting plasma tripeptide described as a healing factor and albumin’s Asp-Ala-His amino terminus, a copper-binding motif reviewed in 2018 (29336493). Replacing glycine with alanine retains internal histidine and terminal lysine while adding a methyl side chain, producing the sequence declared here.

Applied work arose through cosmetics. The vitamin-C-conjugate paper notes these tripeptides’ initial development for products directed at collagen synthesis and human skin-fibroblast growth (29567599). In 2007, a Seoul dermatology group tested the complex in dermal papilla and isolated hair follicles in vitro (17703734). Later reviews still rely on that experiment when discussing it (42072405). Sources: PMID 29336493; PMID 29567599; PMID 17703734; PMID 42072405.

GHK-Cu is the only same-class catalog reference. The complexes share internal histidine, terminal lysine and copper coordination associated with the Xxx-His amino-terminal family, differing by the initial residue’s methyl group (29336493). Their evidence bases differ: glycine-complex work concerns skin fibroblasts and healing, while AHK-Cu work concerns dermal papilla and follicles (17703734, 42072405). Different models and groups do not produce directly comparable figures.

GLOW and KLOW contain the glycine complex, not AHK-Cu, so their declared copper ingredient belongs to another record. KPV is also a tripeptide but does not coordinate a metal and is studied in intracellular signaling. A short chain does not imply the same binding site or target. Sources: PMID 29336493; PMID 17703734; PMID 42072405.

There are no human trials, including exploratory ones. Published human-tissue work stops at follicles maintained in culture (17703734). There is no independent replication using the copper complex; the later paper changed both molecule and model (29567599). No indexed publication examines AHK-Cu in animals.

Within the 2007 experiment, apoptotic-cell counts decreased without statistical significance while pathway markers shifted in the expected direction (17703734). The 2026 review records rather than resolves that discordance (42072405). Contribution of peptide versus carried copper also remains unresolved: family chemistry includes ion exchange among ligands and albumin in vitro (34730942), but no study separates those contributions to the observed response. Sources: PMID 17703734; PMID 29567599; PMID 34730942; PMID 42072405.